Osier FHA


12 results

Phagocytosis of Plasmodium falciparum ring-stage parasites predicts protection against malaria.Musasia FK, Nkumama IN, Frank R, Kipkemboi V, Schneider M, Mwai K, Odera DO, Rosenkranz M, Furle K, Kimani D, Tuju J, Njuguna P, Hamaluba M, Kapulu MC, Wardemann H, CHMI-SIKA Study Team, Osier FHA
Nat Commun, (2022). 13:4098

Distinct kinetics of antibodies to 111 Plasmodium falciparum proteins identifies markers of recent malaria exposure.Yman V, Tuju J, White MT, Kamuyu G, Mwai K, Kibinge N, Asghar M, Sundling C, Sonden K, Murungi L, Kiboi D, Kimathi R, Chege T, Chepsat E, Kiyuka P, Nyamako L, Osier FHA, Farnert A
Nat Commun, (2022). 13:331

Malaria vaccine roller coaster.Nkumama IN, Osier FHA
Nat Microbiol, (2021). 6:1345-1346

Smashing Stereotypes: Mutual Respect, Key to Embracing Diversity.Osier FHA, Murungi LM
Trends Parasitol, (2021). 37:265-267

Turning Discoveries into Treatments: Immunology in Africa.Osier FHA, Mwandumba HC, Gray CM
Trends Immunol, (2020). 41:1051-1053

Plasmodium falciparum Merozoite Associated Armadillo Protein (PfMAAP) Is Apically Localized in Free Merozoites and Antibodies Are Associated With Reduced Risk of Malaria.Aniweh Y, Nyarko PB, Charles-Chess E, Ansah F, Osier FHA, Quansah E, Thiam LG, Kamuyu G, Marsh K, Conway DJ, Tetteh KKA, Awandare GA
Front Immunol, (2020). 11:505

Serological Profiling for Malaria Surveillance Using a Standard ELISA Protocol.Murungi LM, Kimathi RK, Tuju J, Kamuyu G, Osier FHA
Methods Mol Biol, (2019). 2013:83-90

Antibody responses to merozoite antigens after natural Plasmodium falciparum infection: kinetics and longevity in absence of re-exposure.Yman V, White MT, Asghar M, Sundling C, Sonden K, Draper SJ, Osier FHA, Farnert A
BMC Med, (2019). 17:22

KILchip v1.0: A Novel Plasmodium falciparum Merozoite Protein Microarray to Facilitate Malaria Vaccine Candidate Prioritization.Kamuyu G, Tuju J, Kimathi R, Mwai K, Mburu J, Kibinge N, Chong Kwan M, Hawkings S, Yaa R, Chepsat E, Njunge JM, Chege T, Guleid F, Rosenkranz M, Kariuki CK, Frank R, Kinyanjui SM, Murungi LM, Bejon P, Farnert A, Tetteh KKA, Beeson JG, Conway DJ, Marsh K, Rayner JC, Osier FHA
Front Immunol, (2018). 9:2866

Vaccine candidate discovery for the next generation of malaria vaccines.Tuju J, Kamuyu G, Murungi LM, Osier FHA
Immunology, (2017). 152:195-206

Changes in Malaria Epidemiology in Africa and New Challenges for Elimination.Nkumama IN, O'Meara WP, Osier FHA
Trends Parasitol, (2017). 33:128-140

Targets and Mechanisms Associated with Protection from Severe Plasmodium falciparum Malaria in Kenyan Children.Murungi LM, Sonden K, Llewellyn D, Rono J, Guleid F, Williams AR, Ogada E, Thairu A, Farnert A, Marsh K, Draper SJ, Osier FHA
Infect Immun, (2016). 84:950-963